Healthtech Startups
16,921 companies tagged Healthtech, with their investors and founders.
Northwind operates a telemedicine platform connecting patients with dermatologists for diagnosis and treatment of chronic skin conditions including psoriasis and atopic eczema, offering customized treatment plans and a line of proprietary topical medications with ongoing follow-up care.
2 investors
Nostopharma develops targeted nanodelivery technology and advanced molecular interventions for bone and soft tissue disorders, using precision medicine approaches to repurpose existing drugs. The company serves clinicians treating patients with conditions like heterotopic ossification and cartilage damage.
2 investors
Hey Nouri provides science-backed pediatric care for childhood metabolic disease, obesity, and related conditions through habit-based coaching and remote support for families. The service combines clinical oversight with behavioral coaching designed for children and adolescents to build healthy habits and prevent long-term health issues.
2 investors
Novai applies advanced molecular and computational approaches to eye disease, supporting clinicians and researchers in translating scientific findings into patient treatment options.
2 investors
NovalGen is a clinical-stage biotechnology company developing multi-specific biologics for oncology, autoimmune, haematological, and metabolic disorders using its proprietary AutoRegulation platform technology.
2 investors
NOVELDA develops Ultra-Wideband (UWB) short-range impulse radar sensors for detecting human presence in indoor environments, serving consumer electronics and smart building applications. The technology enables improved user experience and energy efficiency across various IoT and building automation use cases.
2 investors
Novellia is a consumer health platform that lets people aggregate their medical records from providers, upload and digitize their own documents, and track symptoms and medications in one secure place. It also lets users anonymously contribute their health data to support treatment research and evidence generation.
2 investors
Novo Nordisk is a pharmaceutical company that develops and markets treatments for conditions including diabetes, obesity/weight management, and haemophilia, with products such as GLP-1 therapies. It serves patients and healthcare markets globally.
2 investors
Novocuff is a medical device company developing the Novocuff Cervical Control System, an investigational device aimed at improving outcomes for pregnancies affected by preterm prelabor rupture of membranes (PPROM) or cervical shortening. It focuses on maternal and infant health related to preterm birth complications.
2 investors
Novocure develops Tumor Treating Fields therapy for treating aggressive forms of cancer. The company focuses on patient-centered innovation in oncology.
2 investors
Novoflow provides a patient cancellation and no-show recovery system that integrates with existing EHR platforms to automatically identify, match, and contact patients to reschedule missed appointments.
2 investors
Novoic develops AI-based software that analyzes speech to detect mild cognitive impairment and early-stage Alzheimer's disease, aiming to enable earlier detection. Its products—including automated speech-based cognitive testing (Storyteller), a screening management dashboard, and a speech-processing API—are used by medical centers and research institutions, primarily in the US.
2 investors
SenseBP is a wearable blood pressure monitoring device that eliminates the need for traditional pressure cuffs. The product measures blood pressure at the wrist without compression, targeting patients and consumers who need convenient and accurate health monitoring.
2 investors
Novotech is a contract research organization (CRO) that provides clinical trial execution and scientific advisory services for biotech and biopharma sponsors, including complex cell and gene therapy trials. It has a strong regional focus on the Asia-Pacific market.
2 investors
Noxus provides enterprise AI solutions that automate retail and e-commerce operations, enhance customer engagement, and drive profitability through autonomous AI agents. The platform emphasizes security, compliance, and measurable ROI for retail organizations.
2 investors
NTx Bio develops proprietary cell-free synthetic biology platforms for on-demand, decentralized biomanufacturing of mRNA and proteins. The company serves drug developers and researchers seeking faster, scalable production of therapeutic molecules from concept to commercial manufacturing.
2 investors
Nuanced Health develops healthcare solutions, though the specific product focus is not detailed on this team page.
2 investors
A specialty pharmaceutical company focused on developing and commercializing novel therapeutics for central nervous system conditions, serving patients and healthcare providers.
2 investors
Nuntius develops programmable nanocarriers for drug delivery that can target tissues beyond the liver and utilize machine learning to optimize carrier performance. The company serves pharmaceutical and biotech organizations developing targeted therapeutics.
2 investors
NurseDash operates an on-demand staffing platform that connects clinicians with healthcare facilities to fill shifts. It serves both nurses and healthcare facilities, currently operating in Texas, Ohio, Florida, Pennsylvania, and Illinois.
2 investors
NurseLynx operates Care Connect, an AI-powered on-demand staffing platform that connects healthcare organizations with nursing and care workers. It also offers home care services.
2 investors
Nusano produces medical radioisotopes for use in theranostic compounds and cancer treatment applications. The company serves the healthcare and oncology sectors by making radioisotopes available for targeted radiopharmaceutical therapies.
2 investors
NuSirt Sciences develops therapies that activate the sirtuin pathway by combining established pharmaceuticals and natural products to treat cardiometabolic conditions of aging and overnutrition, including fatty liver disease (MAFLD/MASH), obesity, type 2 diabetes, and hypertension. Its lead drug candidate TRIPLN combines L-leucine, metformin, and sildenafil, and it also markets LEUSIX, a dietary supplement for cardiometabolic health and weight management.
2 investors
Nutrabolt develops sports nutrition and energy drink products designed to enhance physical and mental performance, including pre-workout supplements, energy beverages, and related sports nutrition brands sold through retail and direct-to-consumer channels.
2 investors